1 report

EYEGATE PHARMACEUTICALS INC TABLE ##: CORNEAL NEOVASCULARIZATION - PIPELINE BY EYEGATE PHARMACEUTICALS INC, H## 2018 Corneal Neovascularization - Drug Profiles GENE THERAPY FOR CORNEAL NEOVASCULARIZATION - DRUG PROFILE GENE THERAPY TO ACTIVATE RAVER-## PROTEIN FOR CORNEAL NEOVASCULAR

  • Gene Therapy
  • United States
  • World
  • Product Initiative
  • EyeGate Pharmaceuticals, Inc.